4 results match your criteria: "UCSD Medical Centre[Affiliation]"
Bilateral Superficial Trigeminal Nerve Blocks are not More Effective than a Placebo in Abolishing Post-operative Headache Pain in Pituitary Transsphenoidal Neurosurgery: A Prospective, Randomized, Doubleblinded Clinical Trial.
Rev Recent Clin Trials
August 2023
Department of Anesthesiology, University of California, San Francisco (UCSF) Medical Centre, San Francisco, CA, USA.
Article Synopsis
- The study investigates whether bilateral superficial trigeminal nerve blocks can reduce the need for morphine after pituitary adenoma surgery, as postoperative headaches and nausea often lead to longer hospital stays.
- Forty-nine patients were randomly assigned to receive either the nerve block with ropivacaine or a placebo, with the primary focus on morphine use in the first six hours post-surgery.
- Results showed no significant difference in morphine consumption or other secondary outcomes, suggesting that postoperative headaches may have complex causes not addressed by the nerve block intervention.
Safe Water Community Project in Jalisco, Mexico.
Ann Nutr Metab
August 2020
Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, University of Guadalajara Health Sciences Center, Guadalajara, Mexico,
Few studies have assessed kidney function in patients with gastrointestinal infections in low-resource settings. Although dehydration is a frequent complication of acute diarrhea, we do not know the frequency and severity of acute kidney injury (AKI) in this context. A high prevalence of chronic kidney disease (CKD) has been reported among the inhabitants of poor communities in Poncitlan, Mexico.
View Article and Find Full Text PDF1-hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new treatment for berry aneurysm. III: Initial clinical results.
J Neurointerv Surg
January 2012
Department of Neurosurgery, UCSD Medical Centre, San Diego, CA 91941-7160, USA.
Introduction: As part of an institutionally approved research protocol, patients with cerebral berry aneurysm were enrolled in a clinical trial designed to evaluate the safety of the new moldable liquid embolic agent Neucrylate AN.
Methods: Twelve patients with aneurysms judged to be suboptimal for treatment by standard endovascular or surgical approaches were treated with Neucrylate AN. The agent was injected during temporary balloon occlusion at the neck of the aneurysm.
To intubate or not--that is the question: continuous positive airway pressure versus surfactant and extremely low birthweight infants.
Arch Dis Child Fetal Neonatal Ed
November 2006
Department of Paediatrics/Neonatology, UCSD Medical Centre, 200 West Arbor Drive No 8774, San Diego, CA 92103-8774, USA.
Perspective on the paper by Booth (see page 398)
View Article and Find Full Text PDF